Tau undergoes a plethora of modifications that are critical to its regulation and localization in AD brains, including – but not limited to – polyubiquitination, O-glycosylation, glycation, oxidation and phosphorylation, the latter of which has been most extensively reported (Gong et al., 2005). The gene discussed is MAPT; the disease is Alzheimer disease.